The global biotechnology market is projected to reach over $4 trillion by 2035; the GCC market is expected to reach $2.6 billion by 2028, with the UAE and Saudi Arabia leading the growth in the region ...
Introduction of AVT05 supported by NHS England tender award in the United KingdomREYKJAVIK, ICELAND (December 22, 2025) - ...
In early December, the 2025 updates of China’s NRDL were finalised with a total of 114 drugs, including Western drugs and ...
An Introduction to Doing Business in China 2026 is designed to guide new and established investors in China with updated ...
Learn what to consider when your workspace must be clean and sterile, including hygiene standards, contamination control, ...
TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...
A one-time Enron energy trader and billionaire philanthropist has been quietly exerting influence at the US Food and Drug Administration, in an effort to lower drug prices and reform research ...
The Nation (PK) on MSN
Seed sector reforms gain momentum as regulatory framework modernised
The Ministry of National Food Security and Research provides an overview of ongoing institutional reforms and modernization ...
This year, 84 companies were newly listed on the KOSDAQ market, while 38 companies were delisted. According to the KOSDAQ ...
The global market for Cold Chain Monitoring was valued at US$9.4 Billion in 2024 and is projected to reach US$22.3 Billion by 2030, growing at a CAGR of 15.5% from 2024 to 2030. This comprehensive ...
Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...
In a year of increasing scrutiny on health care and cost of medicines, pharmaceuticals continued to soar in importance for North Carolina through business developments, legislation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results